International Society of Paediatric Surgical Oncology (IPSO) Minimally Invasive Surgery (MIS) Guidelines

Fernandez-Pineda I.; de Campos Vieira Abib S.; Boam T.; Aspiazu Salinas D.; Michael S.; Ted Gerstle J.; Warmann S.; Fuchs J.; Stetson A.; Gonzalez G.; Tiao G.; B. Lautz T.; Chaves Ribeiro R.; Dasgupta R.; Shalkow-Klincovstein J.; Puerta C.; M. Davidoff A.; Cornet M.; Grosman J.; Pire A.; Sarnacki S.; Blanc T.; H Abdelhafeez A. · ecancermedicalscience (2026) · DOI: 10.3332/ecancer.2026.2076

Resumen

Paediatric oncology surgeons play a crucial role in diagnosing, staging, and treating malignant solid tumors. In recent years, many solid tumour protocols have advocated for a more tailored surgical approach to both the primary tumour site and metastatic disease. The integration of Minimally Invasive Surgery (MIS) into paediatric oncology practice has gained popularity over the past few decades. While the benefits of MIS are well established in non-oncologic surgery, its role in paediatric solid tumours is still evolving and, in many cases, lacks high-quality evidence. These IPSO-MIS guidelines guidelines aim to provide practical surgical recommendations for diverse clinical scenarios, addressing the needs of both High-Income Countries (HICs) and Low-and Middle-Income Countries (LMICs). The contributing authors represent both settings, ensuring a comprehensive and inclusive perspective. We hope that these guidelines will contribute to improving outcomes for children with cancer worldwide. © the authors; licensee ecancermedicalscience.